SEARCH

SEARCH BY CITATION

References

  • 1
    Brown AF, Mangione CM, Saliba D et al. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003;51(5 Suppl):S265S280.
  • 2
    Collaborative overview of randomised trials of antiplatelet therapy—I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994;308:81106.
  • 3
    Cooper-DeHoff RM, Gong Y, Handberg EM et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA 2010;304:6168.
  • 4
    Sleight P, Redon J, Verdecchia P et al. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens 2009;27:13601369.
  • 5
    Gerstein HC, Miller ME, Byington RP et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:25452559.
  • 6
    American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care 2013;36(Suppl 1):S11S66.
  • 7
    Inzucchi SE, Bergenstal RM, Buse JB et al. Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:13641379.
  • 8
    American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012;60:616631.
  • 9
    Rubins HB, Robins SJ, Collins D et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;341:410418.
  • 10
    Vijan S, Hofer TP, Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA 2000;283:889896.
  • 11
    Agardh E, Tababat-Khani P. Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care 2011;34:13181319.
  • 12
    Haas L, Maryniuk M, Beck J et al. National standards for diabetes self-management education and support. Diabetes Care 2013;36(Suppl 1):S100S108.
  • 13
    Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393403.
  • 14
    Whooley MA, Avins AL, Miranda J et al. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997;12:439445.
  • 15
    Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull 1988;1988:709711.
  • 16
    Wilson K, Mottram P, Sivanranthan A et al. Antidepressant versus placebo for depressed elderly. Cochrane Database Syst Rev 2001;(2):CD000561.
  • 17
    Furukawa TA, Streiner DL, Young LT. Antidepressant plus benzodiazepine for major depression. Cochrane Database Syst Rev 2001;(2):CD001026.
  • 18
    Mottram P, Wilson K, Strobl J. Antidepressants for depressed elderly. Cochrane Database Syst Rev 2006;(1):CD003491.
  • 19
    Katon WJ, Lin EH, Von Korff M et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med 2010;363:26112620.
  • 20
    Katon WJ, Von Korff M, Lin EH et al. The Pathways Study: A randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004;61:10421049.
  • 21
    Rubenstein LZ, Josephson KR, Osterweil D. Falls and fall prevention in the nursing home. Clin Geriatr Med 1996;12:881902.
  • 22
    Campbell AJ, Robertson MC, Gardner MM et al. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: A randomized, controlled trial. J Am Geriatr Soc 1999;47:850853.
  • 23
    Fuller GF. Falls in the elderly. Am Fam Physician 2000;61:21592168, 2173–2154.
  • 24
    Lu FP, Lin KP, Kuo HK. Diabetes and the risk of multi-system aging phenotypes: A systematic review and meta-analysis. PLoS One 2009;4:e4144.
  • 25
    Biessels GJ, Staekenborg S, Brunner E et al. Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol 2006;5:6474.
  • 26
    Allen KV, Frier BM, Strachan MW. The relationship between type 2 diabetes and cognitive dysfunction: Longitudinal studies and their methodological limitations. Eur J Pharmacol 2004;490:169175.
  • 27
    Knopman DS, DeKosky ST, Cummings JL et al. Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:11431153.
  • 28
    Brown JS, Vittinghoff E, Wyman JF et al. Urinary incontinence: Does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc 2000;48:721725.
  • 29
    Dugan E, Cohen SJ, Bland DR et al. The association of depressive symptoms and urinary incontinence among older adults. J Am Geriatr Soc 2000;48:413416.
  • 30
    Chu LW, Chi I, Chiu AY. Incidence and predictors of falls in the Chinese elderly. Ann Acad Med Singapore 2005;34:6072.
  • 31
    Chang JT, Ganz DA. Quality indicators for falls and mobility problems in vulnerable elders. J Am Geriatr Soc Oct 2007;55(Suppl 2):S327S334.
  • 32
    Bril V, England J, Franklin GM et al. Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011;76:1758.
  • 33
    American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009;57:13311346.